MAP microba life sciences limited

I agree with your analysis.The transaction is disappointing...

  1. 10,126 Posts.
    lightbulb Created with Sketch. 1041
    I agree with your analysis.
    The transaction is disappointing IMO.

    The worlwide distribution agreements in place have not yet provided much fruit. Definitely not what Dr Luke Reid was promoting at the IPO.

    Microba is valuing the company at 30% less than the market was while carrying out this acquisition at 23 cents a share.
    I think its a big mistake. They state that Invivo is cashflow neutral but no doubt in Microba's hands it will have added costs in pushing for growth and expanding the product range with Microba products. Also the current owners probably ran the company on a shoestring and now probably have wages that are more in line with market.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.2¢
Change
0.000(0.00%)
Mkt cap ! $47.38M
Open High Low Value Volume
9.3¢ 9.3¢ 9.2¢ $4.641K 50K

Buyers (Bids)

No. Vol. Price($)
5 11774 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 114482 1
View Market Depth
Last trade - 15.57pm 30/07/2025 (20 minute delay) ?
MAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.